Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
In major European markets Germany, France, the U.K., Scandinavia biosimilar adoption for reference products like adalimumab, infliximab, and etanercept has been rapid and deep, with some reference products losing 80-90% of their market share within 12-18 months of biosimilar entry
Muskiet MHA, Tonneijck L, Smits MM, van Baar MJB, Kramer MHH, Hoorn EJ, et al
Weight loss should not be the goal of recovery from BED
doi:10.1002/hep.20800
Educating ourselves about the factors that influence our wellness journey is essential in promoting long-term health
10.1007/s00204-023-03660-8 Arch Toxicol
US$ 27.15
US$ 27.95
US$ 29.20
US$ 25.38
US$ 26.08
US$ 25.85
US$ 24.60
US$ 28.64
US$ 25.34
